期刊文献+

辅酶Q_(10)纳米裸晶的平衡溶解度与粒径无关的证明

Equilibrium solubility of naked nanocrystals is not related to particle size
下载PDF
导出
摘要 目的考察滤膜的固液分离能力及对药物的吸附情况,选择最佳固液分离条件,研究辅酶Q10(coenzyme Q10,CoQ10)纳米裸晶粒径与溶解度的关系。方法采用溶剂/反溶剂法制备CoQ10纳米裸晶混悬液。考察不同体积分数乙醇中,不同滤膜及其组合对药物的吸附能力和对制剂与原料药的固液分离能力。以稀释法测定CoQ10纳米裸晶与原料药在四种溶剂系统中的平衡溶解度。测定87.6nm CoQ10纳米裸晶及原料药的溶解曲线,提出"界面溶解度"的新概念,并研究粒径与界面溶解度的关系。结果滤膜的吸附能力的顺序为0.05μm PC膜>0.22μm PA膜>0.05μm PVDF膜>0.22μm PVDF膜>0.10μm PES膜,当乙醇体积分数大于等于70%时,后3种滤膜对药物均无吸附。制剂和原料药的最佳固液分离滤膜组合为0.22μm PVDF+0.05μm PVDF+0.22μmPVDF及0.22μm PVDF+0.22μm PVDF。粒径分别为114.8、85.1、77.4、58.9 nm的CoQ10纳米裸晶与原料药在4种醇水系统中的平衡溶解度分别为0.82~0.88、4.40~4.74、16.70~17.43、31.75~33.04 mg.L-1。纳米裸晶与原料药在稀释后呈现完全不同的溶解曲线,前者药物浓度迅速上升出现显著的过饱和而后下降至一个平台值;后者药物浓度逐渐增加达到相同的平台值。结论 粒径与平衡溶解度无关,与界面溶解度有关。 Objective To investigate solid-liquid separation and absorption of coenzyme Q10(CoQ10)by millipore filters,chose the best solid-liquid separation condition and study the relationship between particle size and solubility with naked CoQ10 nanocrystals under chosen conditions.Methods The precipitation method was used to prepare CoQ10 nanocrystals.The absorption was researched at different concentrations of ethanol and the solid-liquid separation was performed for both nanocrystals and bulk drugs.The dilution-dissolution method was employed to determine the equilibrium solubility of CoQ10 nanocrystals and bulk drugs in four ethanol-water solvents.The new concept of"interfacial solubility,Sif"was proposed and the dissolution curves of 87.6 nm CoQ10 nanocrystals and bulk drug were used to study the relationship between particle size and interfacial solubility.Results The absorption order of the drug to millipore filters was 0.05 μm PC,0.22 μm PA,0.05 μm PVDF,0.22 μm PVDF and 0.10 μm PES.The latter three filters had no absorption when the concentration of ethanol was not less than 70%(φ).The optimal solid-liquid separation condition for nanocrystals was 0.22 μm PVDF+0.05 μm PVDF+0.22 μm PVDF,and for bulk drugs was 0.22 μm PVDF+0.22 μm PVDF.The equilibrium solubility of CoQ10 nanocrystals(with particle sizes of 114.8 nm,85.1 nm,77.4 nm and 58.9 nm)and bulk drugs in four ethanol-water solvents were 0.82-0.88,4.40-4.74,16.70-17.43,31.75-33.04 mg·L-1,respectively.Under diluted conditions,the micro difference in interfacial layer between nanocrystals and bulk drug was enlarged and displayed special solublization curves.For nanocrystals,the concentration of the drug quickly increased to a supersaturated state and then decreased gradually to a plateau.While for bulk drug,the concentration of the drug increased gradually to a plateau equal to that of nanocrystals,which demonstrated the same equilibrium solubility.Conclusions The particle size is related to"interfacial solubility"rather than
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第8期585-593,686,共10页 Journal of Shenyang Pharmaceutical University
基金 国家重点基础研究发展计划(973计划)项目(2009 CB930300)的资助
关键词 粒径 溶解度 平衡溶解度 界面溶解度 Ostwald-Freundlich 微孔滤膜 纳米裸晶 particle size solubility equilibrium solubility interfacial solubility Ostwald-Freundlich equation millipore filter naked nanocrystal
  • 相关文献

参考文献32

  • 1ALSENZ J, KANSY M. High throughput solubility measurement in drug discovery and developmentl J]. Adv Drug Deliv Rev ,2007,59(7 ) :546 -567. 被引量:1
  • 2HUANG L F,TONG W Q. Impact of solid state prop- erties on developability assessment of drug candidates [ J]. Adv Drug Deliv Rev,2004,56(3 ) :321 - 334. 被引量:1
  • 3邓意辉,孙姣.纳米裸晶的平衡溶解度与粒径无关[J].沈阳药科大学学报,2011,28(4):258-259. 被引量:2
  • 4AGANTA S, PAXTON J W, BAGULEY B C, et al. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery [ J ]. Int J Pharm, 2009,367 ( 1/2 ) : 179 - 186. 被引量:1
  • 5DOLENC A, KRISTL J, BAUMGARTNER S, et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets [ J ]- Int J Pharm,2009, 376(1/2) :204 -212. 被引量:1
  • 6JUNGHANNS J, MULLER R H. Nanocrystal technol- ogy, drug delivery and clinical applications [ J ]. Int J Nanomed,2008,3 (3) :295 - 309. 被引量:1
  • 7WU Wen-ju, NANCOLLAS G H. A new understand- ing of the relationship between solubility and particle size[ J]1. J Solution Chem, 1998,27 (6) : 521 - 531. 被引量:1
  • 8DUNDON M L, JR E M. The solubility and surface energy of calcium sulfate[ J]. J Am Chem Soc, 1923, 45( 11 ) :2479 -2485. 被引量:1
  • 9HECQ J, DELEERS M, FANARA D, et al. Prepara- tion and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine [ J ]. Int J Pharm,2005,299(1/2) :167 -177. 被引量:1
  • 10JINNO J I, KAMADA N, MIYAKE M, et al. Effect of particle size reduction on dissolution and oral absorp- tion of a poorly water-soluble drug, cilostazol,in bea- gle dogs [ J ]. J Control Release, 2006, 111 ( 1/2 ) : 56 - 64. 被引量:1

二级参考文献38

  • 1苏建勇,龚承元,朱孟府.荷电微孔滤膜去除细菌内毒素的试验研究[J].军事医学科学院院刊,1995,19(4):289-292. 被引量:20
  • 2齐钦华.微孔滤材的性能与应用[J].安徽医药,2005,9(4):301-302. 被引量:4
  • 3单亚.滤膜吸附对部分口服药物溶出度的干扰试验研究[J].安徽医药,2007,11(2):118-119. 被引量:7
  • 4国家药药典委员会编.中华人民共和国药典.二部附录X C,北京:化学工业出版社,2005. 被引量:1
  • 5中国药品生物制品检定所编.中国药品检验标准操作规范.北京:中国医药科技出版社,2005. 被引量:2
  • 6国家药药典委员会编.中华人民共和国药典.二部,北京:化学工业出版社,2005. 被引量:1
  • 7Shoufeng Li,SuiMing Wong,Sundeep Sethia,Hassan Almoazen,Yatindra M. Joshi,Abu T. M. Serajuddin.Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH[J]. Pharmaceutical Research . 2005 (4) 被引量:1
  • 8Wenju Wu,George H. Nancollas.A New Understanding of the Relationship Between Solubility and Particle Size[J]. Journal of Solution Chemistry . 1998 (6) 被引量:1
  • 9JINNO J I,KAMADA N,MIYAKE M,et al.Effect ofparticle size reduction on dissolution and oral ab-sorption of a poorly water-soluble drug,cilostazol,inbeagle dogs. Journal of Controlled Release . 2006 被引量:1
  • 10BIRADAR S V,PATIL A R,SUDARSAN G V,etal.A comparative study of approaches used to im-prove solubility of roxithromycin. Powder Techn-ol . 2006 被引量:1

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部